Pain
Conference Coverage
Children may develop prolonged headache after concussion
CHARLOTTE, N.C. – Headache after pediatric concussion may present as migraine, chronic daily headache, tension-type...
News from the FDA/CDC
FDA announces approval of fifth adalimumab biosimilar, Abrilada
Pfizer said that current plans are to launch the drug in the United States in 2023.
Feature
Support for medical marijuana transcends political affiliation
Use by cancer patients supported by over 80% of survey respondents, regardless of party.
Conference Coverage
Opioid reduction works after minimally invasive gynecologic surgery
VANCOUVER – Two randomized trials show a reduction in prescribed opiates decreases postoperative usage with no loss...
Case Reports
45-year-old woman • fever and chills • diffuse abdominal pain • shortness of breath • Dx?
► Fever and chills
► Diffuse abdominal pain
► Shortness of breath
Opinion
CBD: What physicians need to know about it
An internist describes the benefits and risks of using cannabidiol to treat various conditions.
From the Journals
Opioids, benzodiazepines carry greater risk of COPD-related hospitalization
The risk of hospitalization because of respiratory events for patients with COPD was especially high when opioid and benzodiazepine medications...
From the Journals
Clinical interventions for global drug use need updating
Illicit drug use patterns around the world are changing rapidly, but interventions aimed at reducing harm are not keeping up with evidence.
Pearl of the Month
Is carpal tunnel syndrome the tip of the iceberg?
Dr. Douglas Paauw presents a case involving a patient with no clear reasons for having clinical heart failure.
Feature
Drug crisis continues to evolve beyond opioids
Primary care physicians “are well intentioned but underprepared and may miss some of the drug misuse risks affecting their patients,” says the...
News from the FDA/CDC
FDA approves Reyvow for acute migraine treatment
The approval of lasmiditan (Reyvow) is based on a pair of randomized, double-blind, placebo-controlled trials that included more than 3,000...